David Shih

9PUBLICATIONS
66CO-AUTHORS
Professional ethicsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 15, 2026
Multidisciplinary blinded randomized expert evaluation of large language models for clinical diagnosis and management.

|Jan 02, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma.

Natalie L Silver, Jin Dai, Travis D Kerr

|May 22, 2025
Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1.

Yantao Liu, Yu Peng, Chen Song

|Feb 14, 2024
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer.

Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao

|Jul 19, 2022
Biomolecular Condensation: A New Phase in Cancer Research.

Anupam K Chakravarty, Daniel J McGrail, Thomas M Lozanoski

|Feb 17, 2022
CNGPLD: case-control copy-number analysis using Gaussian process latent difference.

David J H Shih, Ruoxing Li, Peter Müller

Pageof 2

Frequent Collaborators

2 joint publications

Daniel J McGrail

2 joint publications

Nidhi Sahni

1 joint publications

Naema Nayyar

1 joint publications

Corey M Gill